The pharmacy negotiator has blamed the government’s "untested" changes to the April drug tariff for the lack of price concessions issued this month, which have left pharmacists wondering whether the government expects “contractors to make a loss”. 

New data has revealed that 20% of pharmacies believe next month’s increase in Pharmacy First minimum thresholds will be “unachievable”, with 13% already unable to deliver enough consultations to meet current targets.  

Pharmacist A.A. Dhand’s next crime novel is set for publication in spring 2025, with a plot inspired by his own experiences of “drugs, dealers and incredible stories of maverick drug-deals”.

The competition authority recently found that Pharmacy2U’s purchase of LloydsDirect did not pose a competition threat… C+D looked at its reasoning

Jardines Pharmacy’s patients can now book consultations and order repeat prescriptions using a new app, its app developer has announced.

The former landlord of the head office of Lloydspharmacy’s holding company has called for the actions of its former owner Aurelius to be independently and fully scrutinised to check compliance with “all relevant laws”.

Among the pharmacy negotiator’s new “top tips” for maximising dispensing income is shopping around for the best medicine prices. 

Offering a travel health service has helped one pharmacy group “plug the gap” amid the sector’s funding shortfall, with one branch alone making almost £412,000 a year from the service. 

Former superintendent pharmacist and National Pharmacy Association (NPA) director Phil Galt has been appointed the new UK managing director of Cegedim Rx. 

Former Sainsbury’s workers claiming enhanced redundancy from the Lloydspharmacy estate will have their case heard in March 2025, despite a possible victory offering “no realistic hope” of full compensation.

C+D can exclusively reveal the locations of 245 Boots branches that have closed in England over the last year - use our interactive map to see where they are. 

Constantly elevated medicines shortages have cost NHS England (NHSE) £220 million more than usual in a year and created “a great deal of extra work” for pharmacists, a new report has found.